Glutamate is often described as the primary excitatory neurotransmitter in the brain, in part, because it may be present in up to 80% of all synapses (Curtis and Johnston 1974; Choi 1988; Harris and Kater 1994; Meldrum 2000; Franks et al. 2002; Javitt et al. 2011) . As such, altered excitatory neurotransmission likely contributes to most CNS diseases (Carlsson and Carlsson 1990; Olney 1990; Brown and Bal-Price 2003; Hynd et al. 2004; Maragakis and Rothstein 2004; Foster and Kemp 2006; Niswender and Conn 2010; Rondard and Pin 2015) . While traditional models of glutamate signaling depict release solely from pre-synaptic terminals and diffusion throughout the synaptic cleft to activate pre-and post-synaptic receptors, it is becoming increasingly evident that excitatory neurotransmission is achieved by an elaborate network expressed across multiple types of cells that regulate signaling within and outside of the synaptic cleft (Herrera-Marschitz et al. 1996; Timmerman and Westerink 1997; Jabaudon et al. 1999; Danbolt 2001; Schoepp 2001; Baker et al. 2002 Baker et al. , 2003 Pirttimaki et al. 2011; Bridges et al. 2012) . In support, astrocytes and neurons express glutamate receptors, transporters, and release mechanisms, and astrocyte to neuron signaling has been shown to be a key determinant of synaptic transmission (Porter and McCarthy 1996; Pasti et al. 1997; Araque et al. 1999; Fellin et al. 2004 Fellin et al. , 2006 Perea and Araque 2005; Haydon and Carmignoto 2006; Panatier et al. 2011; Santello et al. 2012; Perez-Alvarez et al. 2014; Gomez-Gonzalo et al. 2015) . Therefore, decoding the complex molecular and cellular regulation of glutamate could lead to novel opportunities to better understand and treat pathological excitatory signaling.
A critical gap in modeling excitatory signaling is how distinct components of the glutamate system expressed by neurons and astrocytes are coordinated. In these experiments, we tested the hypothesis that neurons regulate the activity of glutamate-related mechanisms expressed by astrocytes. To do this, we examined the neuronal regulation of system xc − (Sxc), a non-canonical glutamaterelease mechanism primarily expressed by astrocytes Kitamura 1980, 1981; Sato et al. 1999; Pow 2001; Zhang et al. 2014) .
Sxc is a key component of glutamate signaling that is implicated in the pathology or treatment of multiple CNS diseases. It contributes to glutamate signaling by coupling the release of non-vesicular glutamate to the intracellular transport of cystine Kitamura 1980, 1981; Sato et al. 1999) . Manipulations that increase Sxc activity have been shown to (i) influence multiple aspects of synaptic transmission and plasticity Xi et al. 2002; Moran et al. 2005; Moussawi et al. 2009 Moussawi et al. , 2011 Kupchik et al. 2012) , (ii) normalize behavior in pre-clinical disease models (Baker et al. 2003 (Baker et al. , 2008 Madayag et al. 2007; Knackstedt et al. 2010; Alajaji et al. 2013; Lutgen et al. 2013) , and (iii) exert therapeutic effects against multiple CNS diseases including drug addiction and schizophrenia (Berk et al. 2008; Amen et al. 2011; Lewerenz et al. 2013; Canavan et al. 2014; Verrico et al. 2014) . Unfortunately, the regulation of Sxc is poorly understood.
In these studies, our primary objective was to evaluate the possibility that neurons regulate astrocyte Sxc activity. In addition, we tested the hypothesis that the pituitary adenylate cyclase-activating peptide (PACAP) is a neuronal factor capable of regulating astrocyte Sxc activity. To do this, we verified that PACAP is expressed by rat cortical neurons and not astrocytes, and that rat cortical astrocytes express PACAP receptors. We then found that application of PACAP to cortical astrocytes increased Sxc activity. Moreover, inhibition of PACAP signaling blocked neuron-induced up-regulation of Sxc. Collectively, these data are consistent with the possibility that altered neuronal activity could give rise to pathological changes in astrocyte functions, including altered Sxc activity which may be present in numerous CNS disorders ranging from drug addiction to schizophrenia.
Material and methods

Animals and materials
These experiments utilized cortical tissues obtained from Sprague-Dawley rats (age was gestational day 15-16 or post-natal day 3-4; sex was undetermined; Envigo, Indianapolis, IN, USA). Experimental procedures were approved by the Marquette University Institutional Animal Care and Use Committee. The primary materials included fetal bovine serum and horse serum (Atlanta Biologicals, Lawrenceville, GA, USA), 14 C-cystine (PerkinElmer, Waltham, MA, USA), PACAP1-38 (California Peptide Research, Napa, CA, USA), and PACAP6-38 (P6-38; Anaspec, Fremont, CA, USA). PACAP1-38 (PACAP) is the endogenous full-length peptide, whereas P6-38 is a truncated version of PACAP and inhibits PACAP receptors (Miyata et al. 1989; Robberecht et al. 1992; Arimura 2007; Vaudry et al. 2009 ).
Cell culture procedures
Purified cortical astrocyte cultures
Purified cortical astrocyte cultures were prepared from postnatal day 3-4 rat pups. In brief, cortical cells were disassociated and then suspended in Neurobasal A media (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum and 1% Glutamax (Thermo Fisher Scientific). Cells were initially grown in 25 cm 2 or 75 cm 2 cell culture flasks. Once confluent, cells were then subjected to prolonged, orbital shaking (250 rpm, approximately 7 g, for 18 h at 37°C), which has been used to yield purified astrocyte cultures (McCarthy and de Vellis 1980) . Purified astrocytes were then plated on 24-well plates, and refreshed with 70% new culture media every 2-3 days.
Purified cortical neuronal cultures
Purified cortical neuronal cultures were prepared from embryonic rat cortical tissue (gestational day 15-16) as previously described (Lobner 2000) . In brief, dissociated cells were suspended in Eagles' minimal essential medium (Earle's salts, glutamine-free) supplemented with glutamine (2 mM), glucose (21 mM), horse serum (5%), and fetal bovine serum (5%). Cells were seeded on 24-well plates. Forty-eight hours later, cytosine arabinoside (at a final concentration of 10 μM) was added to the culture media to inhibit glial reproduction (Dugan et al. 1995) . Neurons were then grown for an additional 11-13 days.
Procedure for preparing mixed cultures was identical to that of obtaining neuronal cultures (see above) except that cytosine arabinoside was not added to the culture media.
Physically separated astrocyte and neuronal cultures
Because the above mixed cultures also contained a limited number of non-astrocyte glial cells, and to determine whether neuronastrocyte communication involves the release of a neuronal factor, we utilized a 'non-contact' co-culture system in which purified astrocytes were physically separated from purified neurons. Note, these cells are referenced in this study as Astrocytes + neuronal-conditioned media (NCM). In these experiments, purified astrocytes were obtained as described above. When astrocytes reached confluency after 13-16 days in vitro (DIV), neuronal cultures were seeded on removable inserts (Corning, Corning, NY, USA) that had been placed into the wells containing astrocytes, such that both cell types were immersed in the media but were not in physical contact. Fourteen days later, downstream experiments to examine the effects of neurons on astrocytes were performed upon removal of the neuronal inserts. As a result, the DIV for these cells was 27-30.
All cell-growing surfaces in culture flasks and 24-well plates were pre-coated with poly-d-lysine (10 mg/L) and laminin (0.4 mg/L). All cell cultures were maintained in humidified 5% CO2 incubators at 37°C.
C-cystine uptake assay
The assessment of system xc − (Sxc) activity is often achieved by measuring intracellular uptake of radiolabeled cystine as this is primarily dependent on Sxc (Liu et al. 2009 Resch et al. 2014; Albano et al. 2015) . Note, we demonstrated that over 85% of 14 Ccystine uptake in our cells was blocked by the Sxc inhibitor sulfasalazine (SSZ; see Fig. 3b ). In contrast, extracellular glutamate is an insensitive indicator of Sxc as this is a product of numerous mechanisms (Swanson et al. 1997; Duan et al. 1999; Perego et al. granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 8 2000; Montana et al. 2004; Hires et al. 2008) . Radiolabeled cystine uptake assays were performed as described previously with minor modifications (Liu et al. 2009 ). In brief, experiments were conducted in a bead bath at 37°C. Cells were washed three times with warm HEPES-buffered saline solution, after which 14 C-cystine was added to the media for 20 min at a final concentration of 0.3 μM. This concentration was used as it is similar to extracellular cystine concentrations in the brain (Baker et al. 2003) . DL-threo-β-hydroxyaspartic acid (10 μM) was added to the culture media to prevent 14 C-cystine uptake by sodium-dependent glutamate transporters. As described below, some of the experiments also involved the addition of the Sxc inhibitor SSZ (300 μM), PACAP, or P6-38. After incubating cells with 14 C-cystine, cells were washed three times with ice-cold HEPES-buffered saline solution, and then solubilized with 1M NaOH solution. One aliquot of cell lysate was used for protein determination using a bicinchoninic acid protein assay, and another aliquot was used for scintillation counting to measure the level of 14 C-cystine uptake. 14 C-cystine content was normalized to protein concentration. Data are presented as CPM/μg of protein.
RNA extraction and cDNA construction
Total RNA was isolated from cell cultures with Trizol Reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's protocol. DNase treatment was applied to all RNA samples to remove potential genomic DNA contamination with a DNA-free kit (Life Technologies, Carlsbad, CA, USA). Assessment of RNA purity and quantity was performed on a NanoVue Plus Spectrophotometer (GE life sciences, Pittsburg, PA, USA). cDNA was constructed from total RNA using the Reverse Transcription System (Promega, Madison, WI, USA) with oligo(dT) primers following the manufacturer's protocol.
Real-time quantitative PCR
Quantitative PCR was performed using a StepOne Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA) and PerfeCTa SYBR Green FastMix with ROX (Quanta Biosciences, Gaithersberg, MD, USA). Relative quantification of target gene expression was normalized to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using the ∆∆Ct method (Schmittgen and Livak 2008) . Primer sequences were as follows: xCT (catalytic subunit of Sxc) forward -5′-AGGGCATACTCCAGAACACG-3′; xCT reverse -5′-ATGCTCGTACCCAATTCAGC-3′; PACAP forward -5′-AACCCGCTGCAAGACTTCTA-3′; PACAP reverse -5′-CTTTGCGGTAGGCTTCGTTA-3′; PAC1R forward -5′-TGCCTGTGGCTATTGCTATG-3′; PAC1R reverse -5′-TTTAGTCCCATCAGGTCGTTG-3′; GAPDH forward -5′-CTCCCATTCTTCCACCTTTGA-3′; and GAPDH reverse -5′-ATGTAGGCCATGAGGTCCAC-3′. Primers were designed to be intron spanning using the online primer design tool Primer3 (http://biotools.umassmed.edu/bioapps/primer3_www.cgi). A single product from amplification was confirmed by melt curve analysis. Amplification efficiency of all genes was determined to be approximately 95%.
Statistics
Statistical analyses were performed using spss Statistics (Version 19; IBM, Armonk, NY, USA). Analysis of variance (anova) was used when comparing data sets that included more than two groups. Bonferroni tests were used for subsequent post hoc analyses of significant effects involving more than two groups. Student's t-tests were used when comparing results from only two groups. In all instances, statistical significance was designated as p < 0.05.
Experiment 1: Neuronal regulation of Sxc
The goal of this experiment was to test the hypothesis that a releasable neuronal factor regulates Sxc activity in astrocytes. To do this, we used two distinct approaches to co-express rat cortical neurons and astrocytes in culture. First, we measured 14 C-cystine uptake in rat mixed cortical cultures (DIV 13-16). The advantage of this approach is that astrocytes are continuously grown in the presence of neurons. A disadvantage of this approach is that these cultures contain a limited number of microglia and oligodendrocytes. In addition, neurons physically contact astrocytes in these cultures. To address these two points, we also measured 14 C-cystine uptake by astrocytes that had been exposed to neuron-conditioned media. To do this, we first generated purified astrocyte cultures as described above. When astrocytes reached confluency (typically 13-16 DIV), neuronal cultures were seeded on removable inserts which were placed into the wells containing astrocytes, such that both cell types were co-cultured yet with no physical contact. Fourteen days later, the neuronal inserts were removed, and 14 C-cystine uptake was measured as described above. Note, the 14-day period represents the time needed for the neurons to mature. The control cells in this experiment were purified astrocyte cultures in which the inserts lacked neurons. Tests using these cells occurred on DIV 27-30.
Experiment 2: Neuronal up-regulation of Sxc requires PACAP receptor signaling
In an effort to begin to unmask the molecular basis of neuronastrocyte signaling that regulates Sxc, we examined the impact of inhibiting PACAP receptors on cystine uptake in rat cortical cultures. Our interest in PACAP stems from previous studies showing that stimulation of PACAP receptors increases the activity of Sxc and GLT-1 (Figiel and Engele 2000; Resch et al. 2014) , both of which are primarily expressed by astrocytes (Rothstein et al. 1994 (Rothstein et al. , 1996 Lehre et al. 1995; Torp et al. 1997; Pow 2001; Zhang et al. 2014) . In this experiment, vehicle or 10 μM P6-38 (see Figiel and Engele 2000 for concentration justification) was applied to rat cortical cultures (DIV 13-16) for 60 min, at which point 14 C-cystine uptake was measured as described above.
Experiment 3: PACAP up-regulates Sxc on astrocytes
In this experiment, we tested the hypothesis that exogenous application of PACAP would significantly up-regulate Sxc activity in purified astrocyte cultures. To test this, PACAP (0-100 nM) was applied to purified astrocyte cultures (DIV 13-16) for 24 h. Afterward, 14 C-cystine uptake was measured as described above. This experiment was also conducted in purified neuronal and mixed cortical cultures, although the predicted outcome was less certain given the likely expression of endogenous PACAP in these cultures. granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.
Experiment 4: Cellular distribution of PACAP and PAC1R in rat cortical cultures
To further examine the possibility that PACAP is a neuronal factor capable of regulating astrocytes, we examined the cellular expression patterns of PACAP and its primary receptor, PAC1R. We were specifically interested in determining whether PACAP was solely expressed in neurons and PAC1R in purified astrocytes. To do this, we used RT-qPCR to measure mRNA expression for PACAP and PAC1R in mixed cultures, purified astrocyte cultures, and purified neuronal cultures (DIV 13-16).
Experiment 5: Regulation of xCT mRNA by neurons and the neuronal factor PACAP
To better understand the observed up-regulation of astrocyte Sxc by neurons or PACAP, we measured xCT mRNA in purified astrocytes and mixed cultures, purified astrocytes ± neuronalconditioned media, and purified astrocytes ± PACAP.
Results
Experiment 1: Neuronal regulation of Sxc
To determine whether neurons are capable of regulating astrocyte Sxc activity, we used two approaches to permit neuronastrocyte signaling. First, astrocyte and neurons were co-cultured upon plating (mixed cultures). This approach is designated in Fig. 1 as DIV 13-16, which refers to the number of days the cells had been cultured. In addition, confluent, purified astrocyte cultures were exposed to neuronal conditioned media (NCM) by placing neurons grown onto an insert into the wells containing the astrocytes for 14 days (as described in the methods for Experiment 1). This approach is designated in Fig. 1 as DIV 27-30. A univariate anova with DIV and culture cellular composition (i.e., astrocytes only or mixed or astrocyte + NCM) as between-subject factors produced a main effect of cell composition [ Fig. 1; F(1,36) = 77.979, p < 0.001] but not a main effect of DIV or an interaction between these variables. These findings illustrate that a releasable neuronal factor significantly up-regulates Sxc activity on astrocytes (see Fig. 1 ). Figure 1 . Neurons up-regulate Sxc activity in astrocytes. Data depict the mean ± SEM levels of 14 C-cystine measured in rat cortical cells (N = 8-12/condition) that had been cultured for 13-16 or 27-30 days in vitro (DIV). Astro, astrocytes; NCM, neuronalconditioned media. *Represents a significant difference from corresponding purified astrocytes, p < 0.001.
Experiment 2: Neuronal up-regulation of Sxc requires PACAP receptor signaling
Previous studies have shown that PACAP increases the activity of Sxc and GLT-1 (Figiel and Engele 2000; Resch et al. 2014) , both of which are primarily expressed by astrocytes (Rothstein et al. 1994 (Rothstein et al. , 1996 Lehre et al. 1995; Torp et al. 1997; Pow 2001; Zhang et al. 2014) . In an effort to reveal the molecular basis of neuron-astrocyte signaling that regulates Sxc, we examined the impact of inhibiting PACAP receptors with P6-38 on 14 C-cystine uptake in rat mixed, purified astrocyte, and purified neuronal cortical cultures. A univariate anova with cell composition and P6-38 treatment (0 or 10 μM) as between-subject variables yielded a significant interaction [ Fig. 2 ; F(2,62) = 73.849, p < 0.001]. To deconstruct the interaction, we compared 14 C-cystine levels in vehicle-treated mixed cultures to every other condition. We found that vehicle-treated cultures containing neurons and astrocytes (i.e., mixed) displayed significantly higher levels of 14 C-cystine, and that this effect was blocked by inhibiting PACAP receptors with P6-38 (Bonferroni, p < 0.001). Interestingly, P6-38 did not alter 14 C-cystine levels in purified astrocyte or in purified neuronal cultures. These data suggest that endogenous PACAPinduced up-regulation of Sxc activity is only present in mixed cortical cultures (see Fig. 2 ). 
Experiment 3: PACAP up-regulates Sxc on astrocytes
To confirm that PACAP promotes Sxc activity in rat cortical astrocytes, we compared 14 C-cystine uptake in mixed cultures, purified astrocyte cultures, and purified neuronal cultures following PACAP application (24 h) in the presence or absence of the Sxc inhibitor SSZ. A univariate anova with culture cell composition and PACAP treatment as between-subject factors produced a significant interaction [ Fig. 3a 
15
*Indicates a significant difference relative to vehicle-treated purified astrocyte cultures, Bonferroni, p < 0.001. (b) Data depict mean ± SEM levels of 14 C-cystine in rat purified astrocyte cultures after 24 h PACAP (0 or 100 nM) assessed in the presence of an Sxc inhibitor sulfasalazine (SSZ, 0 or 300 μM; N = 4/condition). *Indicates a significant difference relative to PACAP vehicle-treated cells that were not exposed to SSZ (-SSZ), Bonferroni p < 0.001.
Although Sxc is primarily associated with astrocytes, we verified that PACAP-induced increases in 14 C-cystine uptake reflect Sxc activity. To do this, we assessed the impact of PACAP on 14 C-cystine uptake by astrocytes in the presence and absence of the Sxc inhibitor SSZ. A univariate anova with PACAP and SSZ treatments as between-subject factors resulted in a significant interaction [ Fig. 3b; F(1,12) = 19.130, p < 0.01]. Post hoc analyses indicated that PACAP increased 14 Ccystine uptake in astrocytes when tested in the absence (Bonferroni, p < 0.001) but not in the presence of SSZ.
Experiment 4: Cellular distribution of PACAP and PAC1R in rat cortical cultures
To further examine the possibility that PACAP is a neuronal factor capable of regulating astrocytes, we assessed the cellular expression patterns of PACAP and its primary receptor, PAC1R (Gottschall et al. 1990; Lam et al. 1990) . A one-way anova with culture cell composition as a between-subject factor yielded a main effect on PACAP mRNA levels [ Fig. 4a; F(2,17) = 294.774, p < 0.001]. Post hoc analyses revealed that mixed and purified neuronal cultures expressed the highest levels of PACAP mRNA (Bonferroni, p < 0.001). In fact, PACAP mRNA was not detectable in purified astrocyte cultures (Fig. 4a) . A one-way anova comparing the cellular distribution of PAC1R mRNA yielded a main effect of cell type [ Fig. 4b ; F(2,17) = 93.863, p < 0.001]. Post hoc analyses revealed expression of PAC1R in every cell type, but with the highest levels evident in mixed cortical cultures (Bonferroni, p < 0.001). Collectively, these results demonstrate that in rat cortical cultures, PACAP is solely expressed in neurons and its primary receptor, PAC1R, is expressed by astrocytes. 
Experiment 5: Neurons and PACAP increase xCT mRNA
To better understand the observed up-regulation of astrocyte Sxc activity by neurons or PACAP, we measured mRNA levels of xCT, the functional subunit of Sxc (Sato et al. 1999 (Sato et al. , 2000 Bridges et al. 2001) . Mixed cultures of astrocytes and neurons [t(6) = 17.734, p < 0.001], as well as purified astrocyte cultures exposed to NCM [t(13) = 13.431, p < 0.001], expressed significantly higher levels of xCT mRNA relative to respective controls (Fig. 5) . Similarly, PACAP application in purified astrocytes also robustly increased xCT mRNA [ Fig. 5; t(10) = 16 .554, p < 0.001]. Together, these results suggest that the up-regulation of astrocyte Sxc by neurons or PACAP may involve increased Sxc expression. Figure 5 . Exposure to neurons and pituitary adenylate cyclase-activating polypeptide (PACAP) increases xCT mRNA in cultured cortical astrocytes. Data depict mean ± SEM levels of xCT mRNA (normalized to respective controls) in rat cortical cells cultures (N = 4-12/condition). Astro refers to purified astrocyte cultures; mixed cells refer to cultures comprised of neurons and astrocytes; neuronal-conditioned media (NCM) refers to neuronal-conditioned media achieved by placing neurons grown on inserts into the culture wells containing astrocytes for 14 days; PACAP treatment was for 24 h at 10 nM. *Indicates a significant difference relative to the respective control, t-test, p < 0.001. granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.
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Discussion
Glutamate signaling is achieved by an elaborate network likely requiring coordinated activity between neurons and astrocytes. In support, both cells express glutamate receptors, transporters, and release mechanisms (Choi 1988; Greenamyre et al. 1988; Coyle and Puttfarcken 1993; Moghaddam and Adams 1998; Araque et al. 1999 Araque et al. , 2014 Tapia et al. 1999; Marino et al. 2001; Franks et al. 2003; Haydon and Carmignoto 2006; Javitt et al. 2011; Santello et al. 2012; Perez-Alvarez et al. 2014) . The purpose of these experiments was to determine whether, and how, neurons regulate components of the glutamate system expressed by astrocytes. To do this, we focused on system xc − (Sxc) as this non-canonical release mechanism has been shown to be expressed primarily by astrocytes Kitamura 1980, 1981; Sato et al. 1999; Pow 2001; Zhang et al. 2014) , significantly contributes to glutamate homeostasis Xi et al. 2002; Melendez et al. 2005) , regulates neuronal activity Moran et al. 2005; Moussawi et al. 2009 Moussawi et al. , 2011 Moussawi and Kalivas 2010; Kupchik et al. 2012) , and has been linked to multiple CNS diseases (Bridges et al. 2012; Lewerenz et al. 2013; Deepmala et al. 2015) . Our major finding is that Sxc activity is significantly increased when astrocytes are exposed to neurons or to neuronal factors, including pituitary adenylate cyclase-activating peptide (PACAP). These findings are significant, in part, because they illustrate a novel form of neuron-astrocyte communication. Hence, pathological changes involving components of the glutamate system expressed by astrocytes, such as Sxc, may stem from aberrant activity of neuronal circuits.
Neuronal regulation of Sxc
In these studies, we found that the uptake of 14 C-cystine was higher in rat cortical cultures comprised of neurons and astrocytes relative to purified astrocyte cultures. One interpretation of these data is that neurons up-regulate Sxc activity in astrocytes. This conclusion, along with findings that neurons are critical in regulating the expression and activity of sodium-dependent glutamate transporters (Swanson et al. 1997; Figiel and Engele 2000) , highlights the need for neurons and astrocytes to display coordinated activity to achieve granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.
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normal glutamate signaling. Alternative interpretations of our data include the possibility that neurons indirectly regulate Sxc activity. For example, neurons may influence the development of astrocytes, which may in turn influence Sxc.
To more directly test the hypothesis that a releasable neuronal factor coordinates Sxc activity on astrocytes, we evaluated the impact of neuronal-conditioned media on 14 C-cystine uptake in cortical astrocytes. In this experiment, purified astrocyte cultures were conditioned to neurons through a non-contact co-culture system, in which neurons seeded on removable inserts were placed in astrocyte cultures for 14 days. Afterward, the neuronal inserts were removed to measure 14 C-cystine uptake into astrocytes. Similar to our earlier finding, we found that cortical astrocytes that were exposed to neuronal-conditioned media displayed significantly higher 14 C-cystine uptake. We did not observe any other difference in the astrocyte cultures exposed to neuronal-conditioned media from those lacking neurons. For example, the protein counts (mean ± SEM: astrocytes, 267.1 ± 6.8 μg/mL; astrocytes exposed to NCM, 254.4 ± 6.0 μg/mL) or cell confluency did not differ. As a result, these findings support the conclusion that neurons are capable of regulating components of the glutamate system expressed on astrocytes.
Regulation of Sxc by the neuropeptide PACAP
In an attempt to identify potential neuronal factors capable of regulating Sxc on astrocytes, we examined the possible involvement of PACAP as this peptide has been shown to be expressed by cortical neurons (Koves et al. 1991; Waschek et al. 1998; Figiel and Engele 2000) and capable of regulating components of the glutamate system expressed by astrocytes, including glutamate transporters GLT-1 and GLAST, in rat cortical glial cultures and Sxc in mouse glial cultures (Figiel and Engele 2000; Resch et al. 2014) . We sought to extend these studies by examining whether neuron-induced up-regulation of 14 C-cystine uptake requires PACAP signaling. Application of P6-38, a truncated version of PACAP that inhibits PACAP receptors including PAC1R and VPAC2R, and also cocaine-amphetamine regulated transcript (CART) receptor (Robberecht et al. 1992; Gourlet et al. 1995; Laburthe et al. 2007; Hawke et al. 2009; Mounien et al. 2009; Journal of Neurochemistry, Vol. 137, No. 3 (May 2016) : pg. 384-393. DOI. This article is © Wiley and permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.
20 Lin et al. 2011) , decreased 14 C-cystine uptake in mixed cortical cultures to the level observed in purified astrocyte cultures. Interestingly, P6-38 did not alter 14 C-cystine uptake in purified astrocytes or neurons. The results obtained in purified neuronal cultures likely reflect the relative lack of Sxc activity in these cells, although it should be noted that low amounts of 14 C-cystine are detected in these cells. The lack of a P6-38 effect in purified astrocytes indicates the lack of endogenous PACAP signaling in these cells. Collectively, these data indicate that neuron-induced regulation of Sxc may involve PACAP signaling.
To further evaluate the conclusion that PACAP is a neuropeptide capable of directly regulating astrocytes, we examined the cellular distribution of mRNA for PACAP and its primary receptor, PAC1R. PACAP mRNA expression in cortical cultures was restricted to neurons, thereby establishing PACAP as a neuropeptide in these cultures. In contrast, both cortical neurons and astrocytes express mRNA for PAC1R, which has been shown to be the most abundant PACAP receptor that is expressed in cortical astrocytes (Zhang et al. 2014) . However, PACAP also stimulates VPAC1 and VPAC2 receptors, which are also expressed by astrocytes (Grimaldi and Cavallaro 1999) . Hence, there is a need to identify the receptor(s) that contributes to the regulation of Sxc by PACAP. Interestingly, we found significantly higher levels of PACAP and PAC1R in mixed cultures comprised of neurons and astrocytes, compared to either cell type cultured alone, which may suggest that astrocytes influence the neuronal PACAP system, although changes in mRNA do not always result in changes in protein expression and function. While future experiments are needed to further explore the potential for astrocyte-neuron communication to be an important determinant of PACAP signaling, our extant results are consistent with the possibility that PACAP is a neuropeptide capable of regulating components of the glutamate system expressed by astrocytes.
Next, we directly tested the hypothesis that PACAP application increases Sxc activity in astrocytes. We found that PACAP application significantly increased 14 C-cystine uptake in rat cortical astrocytes, but not in mixed or purified neuronal cultures. While we anticipated PACAP-induced increases in 14 C-cystine uptake in rat cortical astrocytes and a lack of an increase in purified neuronal cultures as granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.
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these cells generally display little-to-no Sxc activity, we expected a modest increase in the mixed cortical cultures, an outcome we previously observed in mouse cultures (Resch et al. 2014) . Aside from species, the difference between these studies is not clear, but likely reflects the existence of endogenous PACAP signaling. Collectively, these results are consistent with PACAP functioning as a neuronal factor controlling glutamate signaling involving astrocytes.
The nature of PACAP-induced regulation of Sxc in astrocytes is likely complex. For example, we found evidence that application of PACAP for 24 h increased mRNA of xCT, the active subunit for Sxc. While increases in mRNA do not always result in augmented protein, it is important to note that PACAP also up-regulated Sxc activity. Furthermore, elevated xCT mRNA and increased Sxc activity were also evident in astrocytes cultured with neurons. Collectively, these data suggest that neurons influence the expression of Sxc in astrocytes. In addition, however, we found that relatively brief inhibition of PACAP signaling (i.e., 60 min) produced a significant reduction in Sxc activity, which suggests the possibility of post-translational modification. Additional studies are needed to better understand neuron-or PACAPinduced regulation of Sxc.
Altered glutamate signaling likely underlies, at least in part, many disorders of the brain. Hence, it is critical to better understand how coordinated activity across distinct cell types involved in the transmission of this amino acid is achieved. For example, Sxc has been implicated in several CNS diseases (Baker et al. 2003 (Baker et al. , 2008 Chung et al. 2005; Madayag et al. 2007; Knackstedt et al. 2010; Bridges et al. 2012; Lewerenz et al. 2013; Lutgen et al. 2013; Albano et al. 2015; Ching et al. 2015; Deepmala et al. 2015) . Similarly, altered activity of GLT-1 and other glutamate transporters expressed by astrocytes has also been implicated in pathological glutamate transmission (Soni et al. 2014; Jensen et al. 2015; Roberts-Wolfe and Kalivas 2015) . In each case, however, it is unclear how glutamate signaling involving astrocytes may be altered. Collectively, these studies indicate that aberrant neural activity may be a novel factor underlying pathological changes in glutamate stemming from altered regulation of astrocytes. Moreover, PACAP itself is especially interesting in this regard as it has been shown to regulate glutamate uptake and release by astrocytes.
